The effect of interval time of transcatheter arterial chemoembolization with drug-eluting beads on the efficacy and safety of unresectable hepatocellular carcinoma: a case-control study.
환자-대조
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
0 patients, no distant metastasis, and Child Pugh A patients, the long interval group had longer OS than the short interval group.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
No serious treatment-related complications were observed in any of the patients. [CONCLUSION] DEB-TACE performed at intervals longer than 4 weeks has a better prognosis for HCC than DEB-TACE performed within 4 weeks without increasing adverse reactions.
[PURPOSE] To investigate the effect of treatment interval on the efficacy and safety of transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE) in patients with unresectable hepato
- p-value P<0.001
- p-value P<0.05
APA
Deng G, Zhang H, et al. (2025). The effect of interval time of transcatheter arterial chemoembolization with drug-eluting beads on the efficacy and safety of unresectable hepatocellular carcinoma: a case-control study.. Frontiers in oncology, 15, 1679167. https://doi.org/10.3389/fonc.2025.1679167
MLA
Deng G, et al.. "The effect of interval time of transcatheter arterial chemoembolization with drug-eluting beads on the efficacy and safety of unresectable hepatocellular carcinoma: a case-control study.." Frontiers in oncology, vol. 15, 2025, pp. 1679167.
PMID
41189941
Abstract
[PURPOSE] To investigate the effect of treatment interval on the efficacy and safety of transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE) in patients with unresectable hepatocellular carcinoma (HCC).
[METHODS] Retrospective analysis of clinical data of HCC patients admitted to our hospital from December 2015 to December 2023. Kaplan Meier method was used to calculate survival rate, survival curve was plotted, log rank test was used for univariate analysis, and Cox regression model was used to analyze independent prognostic factors. Select cutoff values based on OS using X-tile software for grouping, and compare the impact of time intervals on OS and adverse reactions.
[RESULTS] The median OS of the entire group was 26 months, and the 1-, 3-, and 5-year survival rates were 85.6%, 48.3%, and 41.8%, respectively. Multi factor analysis shows that, BCLC, The occurrence of splenomegaly, targeted therapy, and TACE interval are independent prognostic factors for overall survival. The analysis of treatment interval grouping showed that the cut-off value of TACE time interval was 4 weeks. The group with TACE interval>4 weeks (long interval group) showed better survival benefits than the group with TACE interval<4 weeks (short interval group) (mOS: 47 34 months, P<0.001). The sub group analysis results showed that in the sub group analysis of ECOG grade 0 patients, no distant metastasis, and Child Pugh A patients, the long interval group had longer OS than the short interval group. One week after the second postoperative follow-up and comparison of laboratory indicators between the two groups, the differences in lactate dehydrogenase (LDH) and platelets between the two groups were significant (P<0.05). No serious treatment-related complications were observed in any of the patients.
[CONCLUSION] DEB-TACE performed at intervals longer than 4 weeks has a better prognosis for HCC than DEB-TACE performed within 4 weeks without increasing adverse reactions.
[METHODS] Retrospective analysis of clinical data of HCC patients admitted to our hospital from December 2015 to December 2023. Kaplan Meier method was used to calculate survival rate, survival curve was plotted, log rank test was used for univariate analysis, and Cox regression model was used to analyze independent prognostic factors. Select cutoff values based on OS using X-tile software for grouping, and compare the impact of time intervals on OS and adverse reactions.
[RESULTS] The median OS of the entire group was 26 months, and the 1-, 3-, and 5-year survival rates were 85.6%, 48.3%, and 41.8%, respectively. Multi factor analysis shows that, BCLC, The occurrence of splenomegaly, targeted therapy, and TACE interval are independent prognostic factors for overall survival. The analysis of treatment interval grouping showed that the cut-off value of TACE time interval was 4 weeks. The group with TACE interval>4 weeks (long interval group) showed better survival benefits than the group with TACE interval<4 weeks (short interval group) (mOS: 47 34 months, P<0.001). The sub group analysis results showed that in the sub group analysis of ECOG grade 0 patients, no distant metastasis, and Child Pugh A patients, the long interval group had longer OS than the short interval group. One week after the second postoperative follow-up and comparison of laboratory indicators between the two groups, the differences in lactate dehydrogenase (LDH) and platelets between the two groups were significant (P<0.05). No serious treatment-related complications were observed in any of the patients.
[CONCLUSION] DEB-TACE performed at intervals longer than 4 weeks has a better prognosis for HCC than DEB-TACE performed within 4 weeks without increasing adverse reactions.
같은 제1저자의 인용 많은 논문 (5)
- Case Report: Percutaneous portal-central venous bypass: a novel salvage therapy for refractory variceal bleeding in TIPS-ineligible patients with portal vein tumor thrombus.
- Infiltrative hepatocellular carcinoma Resistance: Integrating Microenvironment, Host Factors, and Therapy.
- Study on the impact of tumor volume change and radiation dose on 4D-CT-based lung ventilation function at mid-treatment adaptive radiotherapy in stage III non-small cell lung cancer.
- Novel Marine Fungus-Derived Mycophenolic Acids That Inhibit Acute Myeloid Leukemia Cell Proliferation.
- Long-term survival in extensive-stage small cell lung cancer: a case report on the integration of interventional bronchoscopy and systemic immunotherapy.